Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis

Abstract

Primary hypophysitis (PH) is a rare disease with a poorly-defined natural history. Our aim was to characterise patients with PH at presentation and during prolonged follow-up. Observational retrospective study of 22 patients was conducted from 3 centres. In 14 patients, PH was confirmed histologically and in the remaining 8 clinically, after excluding secondary causes of hypophysitis. All patients had hormonal and imaging investigations before any treatment. Median follow up was 48 months (25–75%: 3–60). There was a female predominance with a female/male ratio: 3.4:1. Eight out of 22 patients had another autoimmune disease. Headaches and gonadal dysfunction were the most common symptoms. Five patients presented with panhypopituitarism; 17 patients had anterior pituitary deficiency, and 7 had diabetes insipidus. At presentation, 9 patients were treated surgically, 5 received replacement hormonal treatment, and 8 high-dose glucocorticoids from whom 5 in association with other immunosuppressive agents. Six patients showed complete recovery of pituitary hormonal deficiencies while 6 showed a partial recovery during a 5-year follow-up period. No difference was found between patients treated with surgery and those treated medically. The overall relapse rate was 18%. PH can be manifested with a broad spectrum of clinical and hormonal disturbances. Long-term follow-up is required to define the natural history of the disease and response to treatment, since pituitary hormonal recovery or relapse may appear many years after initial diagnosis. We suggest that surgery and immunosuppressive therapy be reserved for exceptional cases.

Key words

pituitary - hypophysitis - autoimmunity - glucocorticoids

• References

• 1 Bellastella G, Maiorino MI, Bizzarro A, Giugliano D, Esposito K, Bellastella A, De Bellis A. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary 2016; 19: 625-642
• 2 Fukuoka H. Hypophysitis. Endocrinol Metab Clin North Am 2015; 44: 143-149
• 3 De Bellis A, Bellastella G, Colella C, Bizzarro A, Bellastella A, Esposito K. Use of serum pituitary antibodies to improve the diagnosis of hypophysitis. Exp Rev Endocrinol Metab 2014; 9: 465-476
• 4 Falorni A, Minarelli V, Bartoloni E, Alunno A, Gerli R. Diagnosis and classification of autoimmune hypophysitis. Autoimmun Rev 2014; 13: 412-416
• 5 Takao T, Nanamiya W, Matsumoto R, Asaba K, Okabayashi T, Hashimoto K. Antipituitary antibodies in patients with lymphocytic hypophysitis. Horm Res 2001; 55: 288-292
• 6 Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR. Pituitary autoimmunity: 30 years later. Autoimmun Rev 2008; 7: 631-637
• 7 Crock PA. Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab 1998; 83: 609-618
• 8 O'Dwyer DT, Smith AI, Matthew ML, Andronicos NM, Ranson M, Robinson PJ, Crock PA. Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase. J Clin Endocrinol Metab 2002; 87: 752-757
• 9 Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR. Autoimmune hypophysitis. Endocr Rev 2005; 26: 599-614
• 10 Sautner D, Saeger W, Ludecke DK, Jansen V, Puchner MJ. Hypophysitis in surgical and autoptical specimens. Acta Neuropathol (Berl) 1995; 90: 637-644
• 11 Leung GK, Lopes MB, Thorner MO, Vance ML, Laws Jr. ER. Primary hypophysitis: a single-center experience in 16 cases. J Neurosurg 2004; 101: 262-271
• 12 Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A. Lymphocytic hypophysitis: a rare or underestimated disease?. Eur J Endocrinol 2003; 149: 363-376
• 13 Lecube A, Francisco G, Rodríguez D, Ortega A, Codina A, Hernández C, Simó R. Lymphocytic hypophysitis successfully treated with azathioprine: first case report. J Neurol Neurosurg Psychiatry 2003; 74: 1581-1583
• 14 Papanastasiou L, Pappa T, Tsiavos V, Tseniklidi E, Androulakis I, Kontogeorgos G, Piaditis G. Azathioprine as an alternative treatment in primary hypophysitis. Pituitary 2011; 14: 16-22
• 15 Schreckinger M, Francis T, Rajah G, Jagannathan J, Guthikonda M, Mittal S. Novel strategy to treat a case of recurrent lymphocytic hypophysitis using rituximab. J Neurosurg 2012; 116: 1318-1323
• 16 Imber BS, Lee HS, Kunwar S, Blevins LS, Aghi MK. Hypophysitis: a single-center case series. Pituitary 2015; 18: 630-641
• 17 Khare S, Jagtap VS, Budyal SR, Kasaliwal R, Kakade HR, Bukan A, Sankhe S. LilaAR Bandgar T, Menon PS, Shah NS. Primary (autoimmune) hypophysitis: a single centre experience. Pituitary 2015; 18: 16-22
• 18 Chiloiro S, Tartaglione T, Angelini F, Bianchi A, Arena V, Giampietro A, Mormando M, Sciandra M, Laino ME, De Marinis L. An overview of diagnosis of primary autoimmune hypophysitis in a prospective single-center experience. Neuroendocrinology 2017; 104: 280-290
• 19 Muhsin SA, Mount DB. Diagnosis and treatment of hypernatremia. Best Pract Res Clin Endocrinol Metab 2016; 30: 189-203
• 20 Gutenberg A, Larsen J, Lupi I, Rohde V, Caturegli P. A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. Am J Neuroradiol 2009; 30: 1766-1772
• 21 Asa SL, Bilbao JM, Kovacs K, Josse RG, Kreines K. Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: A distinct clinicopathologic entity. Ann Intern Med 1981; 95: 166-171
• 22 Pouplard-Barthelaix A, Lepinard V, Luxembourger L, Rohmer V, Berthelot J, Bigorgne JC. Circulating pituitary autoantibodies against cells secreting luteinising and follicle stimulating hormones in children with cryptorchidism. Lancet 1984; 2: 631-632
• 23 Elias KA, Weiner RI. Direct arterial vascularization of estro- gen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci U S A 1984; 81: 4549-4553
• 24 Lin HH, Gutenberg A, Chen TY, Tsai NM, Lee CJ, Cheng YC, Cheng WH, Tzou YM, Caturegli P, Tzou SC. In situ activation of pituitary-infiltrating t lymphocytes in autoimmune hypophysitis. Sci Rep 2017; 7: 434-492
• 25 Molitch ME, Gillam MP. Lymphocytic hypophysitis. Horm Res 2007; 68: 145-150
• 26 Honegger J, Fahlbusch R, Bornemann A, Hensen J, Buchfelder M, Müller M, Nomikos P. Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery 1997; 40: 713-722
• 27 Wang S, Wang L, Yao Y, Feng F, Yang H, Liang Z, Deng K, You H, Sun J, Xing B, Jin Z, Wang R, Pan H, Zhu H. Primary lymphocytic hypophysitis: Clinical characteristics and treatment of 50 cases in a single centre in China over 18 years. Clin Endocrinol (Oxf) 2017; 87: 177-184
• 28 Abe T. Lymphocytic infundibulo-neurohypophysitis and infundibulo-panhypophysitis regarded as lymphocytic hypophysitis variant. Brain Tumor Pathol 2008; 25: 59-66
• 29 McCutcheon IE, Oldfield EH. Lymphocytic adenohypophysitis presenting as infertility. Case report. J Neurosurg 1991; 74: 821-826
• 30 Guaraldi F, Giordano R, Grottoli S, Ghizzoni L, Arvat E, Ghigo E. Pituitary Autoimmunity. Front Horm Res 2017; 48: 48-68
• 31 Lupi I, Cosottini M, Caturegli P, Manetti L, Urbani C, Cappellani D, Scattina I, Martino E, Marcocci C, Bogazzi F. Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis. Eur J Endocrinol 2017; 177: 127-135
• 32 Wada Y, Hamamoto Y, Nakamura Y, Honjo S, Kawasaki Y, Ikeda H, Takahashi J, Yuba Y, Shimatsu A, Koshiyama H. Lymphocytic anhypophysitis: its clinical features. Jpn Clin Med 2011; 2: 15-20
• 33 Patel MC, Guneratne N, Haq N, West TE, Weetman AP, Clayton RN. Peripartum hypo- pituitarism and lymphocytic hypophysitis. QJM 1995; 88: 571-580
• 34 Bayram F, Kelestimur F, Ozturk F, Selcuklu A, Patiroglu TE, Beyhan Z. Lymphocytic hypophysitis in a patient with Graves' disease. J Endocrinol Invest 1982; 21: 193-197
• 35 Sobrinho-Simoes M, Brandao A, Paiva ME, Vilela B, Fernandes E, Carneiro-Chaves F. Lymphoid hypophysitis in a patient with lymphoid thyroiditis, lymphoid adrenalitis, and idiopathic retroperitoneal fibrosis. Arch Pathol Lab Med 1985; 109: 230-233
• 36 Piñol V, Cubiella J, Navasa M, Fernández J, Halperin I, Bruguera M, Rodés J. Autoimmune hepatitis associated with thyroiditis and hypophysitis. A case report. Gastroenterol Hepatol 2000; 23: 123-125
• 37 Ward L, Paquette J, Seidman E, Huot C, Alvarez F, Crock P, Delvin E, Kämpe O, Deal C. Severe autoimmune polyendocrinopathy– candidiasis–ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: responsive to immunosuppressive therapy. J Clin Endocrinol Metab 1999; 84: 844-852
• 38 Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H. Lymphocytic infundibuloneurohypophysitis as a case of central diabetes insipidus. N Engl J Med 1993; 329: 683-689
• 39 Gutenberg A, Hans V, Puchner MJA, Kreutzer J, Bruck W, Caturegli P, Buchfelder M. Primary hypophysitis: clinical-pathological correlations. European J Endocrinol 2006; 155: 101-107
• 40 Honegger J, Buchfelder M, Schlaffer S, Droste M, Werner S, Strasburger C, Störmann S, Schopohl J, Kacheva S, Deutschbein T, Stalla G, Flitsch J, Milian M, Petersenn S, Elbelt U. Pituitary Working Group of the German Society of Endocrinology . Treatment of Primary Hypophysitis in Germany. J Clin Endocrinol Metab. 2015; 100: 3460-3469
• 41 Joshi MN, Whitelaw BC, Palomar MT, Wu Y, Carroll PV. Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clin Endocrinol (Oxf) 2016; 85: 331-339
• 42 Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med 2014; 6: 230
• 43 Bernreuther C, Illies C, Flitsch J, Buchfelder M, Buslei R, Glatzel M, Saeger W. IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis. Brain Pathol 2017; 27: 839-845
• 44 Iwata N, Iwama S, Sugimura Y, Yasuda Y, Nakashima K, Takeuchi S, Hagiwara D, Ito Y, Suga H, Goto M, Banno R, Caturegli P, Koike T, Oshida Y, Arima H. Anti-pituitary antibodies against corticotrophs in IgG4-related hypophysitis. Pituitary 2017; 20: 301-310
• 45 Gu WJ, Zhang Q, Zhu J, Li J, Wei SH, Mu YM. Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review. Medicine (Baltimore) 2017; 96: 6934